These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2901903)

  • 61. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response.
    Raber J; Koob GF; Bloom FE
    J Pharmacol Exp Ther; 1995 Feb; 272(2):815-24. PubMed ID: 7853199
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Demonstration of glucocorticoid receptor-like immunoreactivity in glucocorticoid-sensitive vasopressin and corticotropin-releasing factor neurons in the hypothalamic paraventricular nucleus.
    Uht RM; McKelvy JF; Harrison RW; Bohn MC
    J Neurosci Res; 1988 Apr; 19(4):405-11, 468-9. PubMed ID: 3260289
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oxytocinergic neurons in rat hypothalamus. Dexamethasone-reversible increase in their corticotropin-releasing factor-41-like immunoreactivity in response to osmotic stimulation.
    Dohanics J; Kovacs KJ; Makara GB
    Neuroendocrinology; 1990 May; 51(5):515-22. PubMed ID: 2112729
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of rat hypothalamic corticotropin-releasing factor by reversed-phase, high-performance liquid chromatography with synthetic ovine corticotropin-releasing factor as a marker.
    Hashimoto K; Murakami K; Ohno N; Kageyama J; Hattori T; Aoki Y; Takahara J
    Neuroendocrinology; 1983; 36(4):272-6. PubMed ID: 6602951
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Co-release of endogenous ATP and [3H]noradrenaline from rat hypothalamic slices: origin and modulation by alpha2-adrenoceptors.
    Sperlágh B; Sershen H; Lajtha A; Vizi ES
    Neuroscience; 1998 Jan; 82(2):511-20. PubMed ID: 9466457
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Corticotropin releasing factor (CRF): origin and course of afferent pathways to the median eminence (ME) of the rat hypothalamus.
    Merchenthaler I; Hynes MA; Vigh S; Schally AV; Petrusz P
    Neuroendocrinology; 1984 Oct; 39(4):296-306. PubMed ID: 6387524
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The development of immunoreactive corticotropin-releasing factor (IR-CRF) in the hypothalamus, pancreas and gastrointestinal tract of immature rats].
    Ohtsuka K; Koshimizu T; Ohyama Y; Yokota Y
    Nihon Naibunpi Gakkai Zasshi; 1986 Jan; 62(1):34-44. PubMed ID: 3486137
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of atrial natriuretic peptide on acetylcholine-induced release of corticotropin-releasing factor from rat hypothalamus in vitro.
    Takao T; Hashimoto K; Ota Z
    Life Sci; 1988; 42(12):1199-203. PubMed ID: 2964553
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dopaminergic stimulation of pituitary but not hypothalamic estrogen receptors in ovariectomized rats.
    Carrillo AJ; Steger RW; Chamness GC
    Endocrinology; 1983 May; 112(5):1839-46. PubMed ID: 6131816
    [TBL] [Abstract][Full Text] [Related]  

  • 71. GnRH release from the mediobasal hypothalamus: in vitro inhibition by corticotropin-releasing factor.
    Gambacciani M; Yen SS; Rasmussen DD
    Neuroendocrinology; 1986; 43(4):533-6. PubMed ID: 3018610
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Involvement of dopaminergic receptors in action of corticotropin releasing factor (CRF) under in vitro conditions.
    Radnai Z; Endröczi E
    Acta Physiol Acad Sci Hung; 1979; 54(2):129-39. PubMed ID: 232360
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Glutamic acid decarboxylase- and gamma-aminobutyric acid-like immunoreactivities in corticotropin-releasing factor-containing parvocellular neurons of the hypothalamic paraventricular nucleus.
    Meister B; Hökfelt T; Geffard M; Oertel W
    Neuroendocrinology; 1988 Nov; 48(5):516-26. PubMed ID: 3072487
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evidence for the presence of noradrenergic neurons and their inhibitory action on luteinizing hormone-releasing hormone release in cultured fetal rat hypothalamic cells.
    Héry M; François-Bellan AM; Deprez P; Faudon M; Héry F
    Life Sci; 1993; 52(25):2017-25. PubMed ID: 8099191
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats.
    Lejeune F; Millan MJ
    Eur J Pharmacol; 2003 Mar; 464(2-3):127-33. PubMed ID: 12620504
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased antinociception by alpha-adrenoceptor drugs after spinal cord noradrenaline depletion.
    Post C; Persson ML; Archer T; Minor BG; Danysz W; Sundström E
    Eur J Pharmacol; 1987 May; 137(1):107-16. PubMed ID: 2886347
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dose-response functions of apomorphine, SKF 38393, LY 171555, haloperidol and clonidine on the self-stimulation evoked from lateral hypothalamus and ventral tegmentum.
    Singh J; Desiraju T; Raju TR
    Indian J Physiol Pharmacol; 1996 Jan; 40(1):15-22. PubMed ID: 8864766
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala.
    Smiałowska M; Bajkowska M; Heilig M; Obuchowicz E; Turchan J; Maj M; Przewłocki R
    Neuropeptides; 2001 Apr; 35(2):82-91. PubMed ID: 11384203
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Central alpha-adrenoceptor subtypes involved in the emetic pathway in cats.
    Hikasa Y; Akiba T; Iino Y; Matsukura M; Takase K; Ogasawara S
    Eur J Pharmacol; 1992 Dec; 229(2-3):241-51. PubMed ID: 1362706
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Depletion of noradrenaline in the hypothalamus reduces the febrile responses induced by prostaglandin E2, thyrotropin-releasing hormone and beta-endorphin in rats.
    Lin MT; Chern YF; Chen SY
    Neuropharmacology; 1985 Nov; 24(11):1039-42. PubMed ID: 2934640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.